Thyrotropin-Releasing Hormone Is Induced in the Left Ventricle of Rats with Heart Failure and Can Provide Inotropic Support to the Failing Heart

Circulation

Volumn 109, Issue 18, 2004, Pages 2240-2245

  Jin, Hongkui ^a   Fedorowicz, Grazyna ^a   Yang, Renhui ^a   Ogasawara, Annie ^a   Peale, Franklin ^a   Pham, Thinh ^a   Paoni, Nicholas F ^a,b  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Heart failure; Hormones; Inotropic agents; Myocardial infarction

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; HORMONE PRECURSOR; MESSENGER RNA; PROTEASE PC1; PROTEINASE; PROTIRELIN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PERFORMANCE; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HORMONE SYNTHESIS; INOTROPISM; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; HEART VENTRICLES; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCYTES, CARDIAC; PROPROTEIN CONVERTASE 1; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THYROTROPIN-RELEASING HORMONE;

EID: 2442449236     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000127951.13380.B4     Document Type: Article

References (29)

1. Nillni EA, Sevarino KA. The biology of pro-thyrotropin-releasing hormone derived peptides. Endocr Rev. 1999;20:599-648.
2. Bao LT, Mao TL. Effects of intracerebroventricular administration of thyrotropin-releasing hormone on cardiovascular function of the rat. Neuroendocrinology. 1982;35:173-177.
3. Mattila J, Bunag RD. Sympathetic vasoconstriction and renin secretion cause pressor response to thyrotropin-releasing hormone in rats. J Pharmacol Exp Ther. 1986;238:232-236.
4. Siren AL, Lake CR, Feuerstein C. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res. 1988;62: 139-154.
5. Koskinen LO. Effects of TRH on blood flow and the microcirculation. Ann NY Acad Sci. 1989;553:353-369.
6. Carnell NE, Feng P, Kim UJ, et al. Preprothyrotropin-releasing hormone mRNA and TRH are present in the rat heart. Neuropeptides. 1992;22: 209-212.
7. Wilber JF, Xu AH. The thyrotropin-releasing hormone gene 1998: cloning, characterization, and transcriptional regulation in the central nervous system, heart, and testis. Thyroid. 1998;8:897-901.
8. Socci R, Kolbeck RC, Meszaros LG. Positive inotropic effect of thyrotropin-releasing hormone on isolated rat hearts. Gen Physiol Biophys. 1996;15:309-316.
9. Jin H, Yang R-H, Awad TA, et al. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation. 2001;103:736-742.
10. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
11. Yang R, Bunting S, Gillett N, et al. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 1995;92:262-267.
12. Lai J, Jin H, Yang R-H, et al. Prostaglandin F2a induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol. 1996;271: H2197-H2208.
13. Winer J, Jung KS, Schakel I, et al. Development and validation of real-time quantitative reverse transcription-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41-49.
14. 33P-labeled riboprobes. Cell Vis. 1994;7:53-64.
15. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 2000;19:4046-4055.
16. Nillni EA, Friedman TC, Todd RB, et al. Pro-thyrotropin-releasing hormone processing by recombinant PC1. J Neurochem. 1995;65: 2462-2472.
17. Friedman TC, Loh YP, Cawley NX, et al. Processing of pro-thyrotropin-releasing hormone (pro-TRH) by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes. Endocrinology. 1995;136: 4462-4472.
18. Nillni EA, Luo LG, Jackson IMD, et al. Identification of the thyrotropin-releasing hormone precursor, its processing products and its coexpression with convertase 1 in primary cultures of hypothalamic neurons: anatomic distribution of PC1 and PC2. Endocrinology. 1996;137:5651-5661.
19. Schaner P, Todd RB, Seidah NG, et al. Processing of prothyrotropin releasing hormone by the family of prohormone convertases. J Biol Chem. 1997;272:19958-19968.
20. Akiyama T, Yamazaki T, Ninomiya I. Differential region response of myocardial interstitial noradrenaline levels to coronary occlusion. Cardiovasc Res. 1993;27:817-822.
21. Schoming A, Dart AM, Dietz R. Release of endogenous catecholamines in the ischemic myocardium of the rat, A: locally mediated release. Circ Res. 1984;55:689-701.
22. Shindo T, Akiyama T, Yamazaki T, et al. Regional myocardial interstitial norepinephrine kinetics during coronary occlusion and reperfusion. Am J Physiol. 1996;270:H245-H251.
23. Vaughan DE, Pfeffer MA. Ventricular remodeling following myocardial infarction and angiotensin-converting enzyme and ACE inhibitors. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven; 1996:1193-1205.
24. Hirsch AT, Talsnecs CE, Schunkert H, et al. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
25. Pfeffer MA, Braunwald F, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327: 669-677.
26. Sharpe N, Murphy J, Smith H. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1998;1: 255-259.
27. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
28. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
29. Lechat P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1997;96:2197-2205.